Лучшие подкасты про CCO (2024)

1
Beyond Viral Suppression: A Case Study Addressing Internalized HIV Stigma 12:29

12d ago12:29

12:29

In this episode, Gregory Huhn, MD, MPHTM, uses a case study to explore the reasons healthcare professionals and people living with HIV may want to further optimize ART in the setting of viral suppression. To determine the best outcome for this case study, Dr Huhn discusses the reasons individuals may not be satisfied with daily oral ART and examine…

1
Homologous Recombination Repair (HRR) Testing and Targeted Therapy in Prostate Cancer 48:15

26d ago48:15

48:15

In this episode, Colin C. Pritchard, MD, PhD, a pathologist, and Heather H. Cheng, MD, PhD, a medical oncologist, discuss optimal biomarker testing to guide treatment decisions in advanced prostate cancer, with topics including: Rationale for targeting PARP in prostate cancer with ARI combinations Study design nuances and findings from key randomiz…

1
How to Implement Earlier Hepatitis B Treatment 21:27

28d ago21:27

21:27

In this episode, Mark S. Sulkowski, MD, FIDSA, FAASLD; Tatyana Kushner, MD, MSCE; Paul Y. Kwo, MD; and patient advocate Jacki Chen, PhD, consider barriers and solutions for more expansive HBV treatment in the United States. Topics include: Patient subgroups to consider for treatment outside guideline criteria Adverse event and cost-effectiveness co…

1
Linkage to Care After HBV Diagnosis: Sharing Session 3 16:54

13d ago16:54

16:54

In this episode, Maria Buti, MD, and her patient discuss opportunities to optimize care for people living with hepatitis B virus (HBV), including: Barriers to HBV screening, including patient- and provider-specific barriers (eg, lack of education, failure to disclose or discuss risk factors, perceived low risk, stigma) Applying CDC recommendations …

1
Day of Mourning: Melanie Kowalski-Fleming’s Story 13:21

15d ago13:21

13:21

"Mark was not one to go to the hospital. If he could duct tape or crazy glue it to fix it, he would. This was so much more than what duct tape or crazy glue could fix.” Melanie Kowalski-Fleming’s life changed forever the day her husband fell off a ladder at work. Hear her powerful story. Released: April 8, 2024 File Size: 7.5 MB Length: 13:20 minut…

1
Key HIV Studies From CROI 2024 Influencing Clinical Practice 44:22

25d ago44:22

44:22

In this episode, Joseph J. Eron, Jr., MD, and Monica Gandhi, MD, MPH, discuss the key HIV studies from CROI 2024 that are influencing their clinical practice, including: New data surrounding long-acting ART, including: The CARES study of LA CAB + RPV in a Sub-Saharan African population using a public health approach The IMPAACT 2017 MOCHA study eva…

1
How to Implement Earlier Hepatitis B Treatment 21:27

28d ago21:27

21:27

In this episode, Mark S. Sulkowski, MD, FIDSA, FAASLD; Tatyana Kushner, MD, MSCE; Paul Y. Kwo, MD; and patient advocate Jacki Chen, PhD, consider barriers and solutions for more expansive HBV treatment in the United States. Topics include: Patient subgroups to consider for treatment outside guideline criteria Adverse event and cost-effectiveness co…

1
Comprendre les effets de la sensibilité aux parfums 6:47

1M ago6:47

6:47

Pour certains travailleurs, l’eau de Cologne et les crèmes à mains peuvent sentir bon, mais pour leurs collègues qui présentent une sensibilité aux parfums, elles peuvent avoir des effets désagréables pour la santé. En fait, les réactions aux parfums, comme les maux de tête, les démangeaisons oculaires et les difficultés respiratoires, sont un prob…

1
Making Sense of Scent Sensitivities 5:11

1M ago5:11

5:11

While the scent of cologne or hand lotion may be pleasant to some, for co-workers with sensitivities to fragrances, they may have unpleasant health effects. In fact, reactions to scents, such as headaches, itchy eyes, and difficulty breathing, are a medical condition and recognized disability under the Canada Human Rights Act. Released: March 18, 2…

1
Real-world Perspectives on Novel HER2-Targeted and TROP-2–Directed Therapies in Advanced Breast Cancer 36:29

1M ago36:29

36:29

In this podcast episode, Sara M. Tolaney, MD, MPH, and Melinda Telli, MD, delve into the critical aspects of the current therapeutic landscape for patients with unresectable or metastatic HER2-low, hormone receptor–positive, and triple-negative breast cancer, including: Challenges with the pathologic testing for HER2-low expression Optimal treatmen…

1
The Art of Multidisciplinary Care for Patients With Metabolic Dysfunction–Associated Steatohepatitis 29:38

1M ago29:38

29:38

In this episode, Arun B. Jesudian, MD, and Mazen Noureddin, MD, MHSc, discuss the expert-informed clinical pathway for the multidisciplinary care of patients with MASLD or MASH, current and emerging therapeutics, and management optimization strategies. Presenters: Arun B. Jesudian, MD Associate Professor of Clinical Medicine Division of Gastroenter…

1
Empowering Patients With Education on HBV: Sharing Session 2 16:49

1M ago16:49

16:49

In this episode, Robert Wong, MD, MS, and a patient discuss opportunities to optimize care for people living with hepatitis B virus (HBV), including: Opportunities to improve patient education, including education for expectant mothers with HBV Potential cultural considerations that may result in delayed HBV diagnosis and care Stigma reduction with…

1
Switching HIV ART in Older People With Weight Gain and Cardiovascular Comorbidities 14:42

2M ago14:42

14:42

Listen to Roger Bedimo, MD, MS, FACP, discuss considerations for older people living with HIV, including: Polypharmacy and deprescribing The risk of cardiovascular events with various ART regimens Approaches for managing weight gain Presenter: Roger Bedimo, MD, MS, FACP Professor of Medicine Interim Director, Office of Global Health UT Southwestern…

1
Optimizing ART in Priority Populations: Initiating ART in Transgender Women 12:29

2M ago12:29

12:29

In this episode, Dr. Bedimo discusses best practices for individualized care in transgender women living with HIV, including: Providing services in a gender-affirmative care model Proactive counseling on drug-drug interactions with gender-affirming hormone therapy Strategies to reduce adverse events Presenter: Roger Bedimo, MD, MS, FACP Professor o…

1
COVID-19 Case Challenges: Employing Outpatient Antivirals and Addressing Drug‒Drug Interactions 34:26

2M ago34:26

34:26

In this episode, Renslow Sherer, MD, and Trinh P. Vu, PharmD, BCIDP, discuss how to optimize the use of COVID-19 antivirals and how to navigate drug-drug interactions between COVID-19 treatments and a patient’s home medications. Their discussion includes: Current COVID-19 landscape COVID-19 testing and vaccination recommendations Treatment guidelin…

1
Breaking Down the Headlines: Addressing the Buzz Around Incretin-Based Therapies With Patients 32:19

2M ago32:19

32:19

In this episode, Jennifer Green, MD, and Carol Hatch Wysham, MD, break down the latest headlines on incretin-based therapies and how to address these topics with patients. Their discussion includes: Beneficial effects beyond glycemic control Adverse events and how to manage them Non- or partial responders and the importance of setting expectations …

1
The Language of Equity, Inclusion, and Leadership: Revisiting our Conversation with Dahabo Ahmed-Omer, CEO of Black North 32:18

3M ago32:18

32:18

At our 2023 Page Annual Conference, Dahabo Ahmed-Omer, CEO of Black North, joined a panel to share her experiences as a CEO and as a black, Muslim woman in Canada as well as actionable, candid advice on having tough conversations on DEI. If your organization’s DEI efforts have waned or are being impacted by the recent wave of anti-DEI sentiment, le…

1
New Audio Updates: CCO Independent Conference Coverage of Hepatitis B at AASLD 2023 37:12

3M ago37:12

37:12

In this episode, Nancy Reau, MD, discusses new data on hepatitis B virus presented at AASLD 2023, including: Current therapies Studies 108 and 110: Factors Linked With Lack of Virologic Suppression After 8 Yr of TAF or TDF Kaiser Permanente Northern California: HCC or Death With TDF vs ETV for Chronic Hepatitis B Early vs Late Postpartum Cessation …

1
Musculoskeletal Disorders and Mental Health 17:41

3M ago17:41

17:41

Dr. Heather O’Reilly (nee Johnston) from McMaster University discusses the connection between musculoskeletal disorders and psychological factors, and what workplaces and workers can do to limit risks for injuries. Released: February 1, 2024 File Size: 10 MB Length: 17:40 minutes ------------------------- « Musculoskeletal Disorders and Mental Heal…

1
Reconsidering Your Approach: Strategies to Support PrEP Persistence and Reengagement 27:00

3M ago27:00

27:00

In this episode, LaRon E. Nelson, PhD, RN, FNP, FNAP, FNYAM, FAAN, discusses the role that healthcare professionals (HCPs) may be playing in their patients’ pre-exposure prophylaxis (PrEP) persistence and strategies to modify their approach to encourage persistence, from Clinical Care Options (CCO), including: Racial disparities in the PrEP care co…

1
My Journey With HBV and HDV: Sharing Session 1 15:19

3M ago15:19

15:19

In this episode, Nancy Reau, MD, and her patient discuss opportunities to optimize care for people living with hepatitis B virus and hepatitis delta virus, including: The importance of patient education along the care continuum Ensuring smooth transitions of care and communication between medical teams Screening hepatitis delta in persons with chro…

1
Why I Started and Why I Stayed on HIV PrEP 6:15

3M ago6:15

6:15

In this episode, David Saunders discusses the value of nonstigmatizing discussions between people using HIV pre-exposure prophylaxis (PrEP) and healthcare professionals, including: Encouraging accountability to individualize adherence strategies and improve persistence to PrEP Reducing stigma, discrimination, and prejudice in healthcare settings to…

1
Long-Acting PrEP: Strategies to Support PrEP Persistence and Reengagement 29:38

3M ago29:38

29:38

In this episode, Sarah M. Wood, MD, MS, discusses data and recommendations for long-acting pre-exposure prophylaxis (PrEP) as a strategy to support PrEP persistence and engagement for adolescents, including: The PrEP care continuum for adolescents System barriers to PrEP coverage and privacy concerns for adolescents The benefits and challenges of s…

1
Cold Feet Prevention: Steps to Stay Safe and Warm When Working Outdoors 6:59

3M ago6:59

6:59

With all the walking, standing, and working workers do on their feet, they can be exposed to potential injury. In winter, cold weather afflictions like frostbite, chilblains, and trench foot can cause painful and sometimes serious consequences. Tune in to this CCOHS podcast to earn more about the harm that working in cold weather can cause feet, an…

1
Pour ne plus avoir froid aux pieds : comment rester au chaud et en sécurité lorsqu’on travaille dehors 8:59

3M ago8:59

8:59

À tellement marcher, être debout et travailler sur leurs deux pieds, les travailleurs les exposent à des blessures potentielles. En hiver, les maux liés au temps froid comme les gelures, les engelures et le pied de tranchée peuvent avoir des conséquences douloureuses et parfois graves. Ne manquez pas ce balado du CCHST pour en apprendre davantage s…

1
Jesus: Demon or Deity 28:37

4M ago28:37

28:37

Jesus: Demon or Deity - recorded Dec 3rd, 2023 --- Send in a voice message: https://podcasters.spotify.com/pod/show/ccoctx/message

1
RSV Vaccines in Adults: A Risk-Based Approach 9:40

4M ago9:40

9:40

In this episode, Angela Branche, MD, discusses RSV vaccines in older adults, including: Current Advisory Committee on Immunization Practices recommendations Risk factors associated with severe RSV disease, including RSV-related hospitalizations Approach to stratifying risk factors (eg, age, comorbidities) in determining which adults may benefit fro…

1
Current Considerations for Adverse Event Management With HER3-Directed Agents 12:33

4M ago12:33

12:33

The third and final episode in a 3-part series covers the safety profile of and considerations for managing adverse events associated with HER3-targeted antibody–drug conjugates, including patritumab deruxtecan (HER3-DXd) and others, in the setting of lung cancer. Presenters in this series include: Rebecca S. Heist, MD, MPH Associate Professor of M…

1
Unpacking the Potential of HER3-Targeted Therapy in NSCLC 15:24

4M ago15:24

15:24

This second episode in a 3-part series on HER3-targeted agents in NSCLC covers current clinical trials with HER3-targeted therapy, including: Recent data on patritumab deruxtecan (HER3-DXd) in the HERTHENA-Lung01 trial The EGFRxHER3 bispecific antibodies BL-B01D1 and izalontamab The HER2xHER3 bispecific antibody zenocutuzumab The HER3-targeted anti…

1
Recent Advances in ADCs and Rationale for HER3 as a Target in Lung Cancer 8:54

4M ago8:54

8:54

This first episode in a 3-part series tackles the role of HER3 in cancer, specifically in NSCLC, and how HER3 can be effectively targeted with ADCs. Presenters in this series include: Rebecca S. Heist, MD, MPH Associate Professor of Medicine Harvard Medical School Medical Oncology Massachusetts General Hospital Boston, Massachusetts Helena Yu, MD A…

1
How to Implement Earlier Hepatitis B and Hepatitis Delta Screening 27:52

4M ago27:52

27:52

In this episode, Douglas Dieterich, MD, leads a panel discussion with Camilla S. Graham, MD, MPH, and Robert Wong, MD, MS, to consider advantages and barriers to universal screening for chronic HBV infection and universal HDV screening in adults with HBV in the United States. Topics include: Updated CDC recommendations for one-time universal screen…

1
How to Implement Earlier Hepatitis B and Hepatitis Delta Screening 27:52

4M ago27:52

27:52

In this episode, Douglas Dieterich, MD, leads a panel discussion with Camilla S. Graham, MD, MPH, and Robert Wong, MD, MS, to consider advantages and barriers to universal screening for chronic HBV infection and universal HDV screening in adults with HBV in the United States. Topics include: Updated CDC recommendations for one-time universal screen…

1
Q&A on HIV PrEP: Episode 7 for Advanced Practice Providers 28:06

4M ago28:06

28:06

In this episode, Tavell L. Kindall, PhD, DNP, ARNP, FNP-BC, AACRN, AAHIVS, FAANP, and Anne Teitelman, PhD, FNP-BC, FANNP, FAAN, discuss key PrEP considerations for advanced practice providers in primary care settings, including: The importance of having PrEP navigators to help with logistics and be a point of contact for patients Where to find educ…

1
Mental Health Challenges: Dialogues on Optimizing Engagement in HIV Care 43:58

4M ago43:58

43:58

In this podcast episode, Mark Brennan-Ing, PhD, and Nina I. Martinez discuss mental health challenges in people living with HIV and much-needed strategies to overcome these challenges to optimize engagement in HIV care, including: The increased rates of mental health disorders and substance use among people living with HIV How mental health disorde…

1
Starting ART: Dialogues on Optimizing Engagement in HIV Care 42:27

4M ago42:27

42:27

In this podcast episode, Isolde Butler, MD, MPH, a healthcare professional caring for people living with HIV, and Marissa Gonzalez, an individual living with HIV, discuss strategies to improve healthcare professionals’ competencies in delivering optimal HIV care from the start to better support patients in overcoming barriers to sustained care enga…

1
Engagement in Care: Dialogues on Optimizing Engagement in HIV Care 30:03

4M ago30:03

30:03

In this podcast episode, Babafemi Taiwo, MBBS, and Vincent Crisostomo discuss the evolving treatment landscape for aging people living with HIV, encompassing the clinical and external resources necessary to support physical and psychosocial health. The topics discussed include: • Mindful prescribing and understanding the impact an HIV diagnosis can…

1
Providing Options for PrEP Reengagement: Strategies to Support PrEP Persistence and Reengagement 16:11

4M ago16:11

16:11

In this episode, Kevin Astle, PharmD, BCPS, BCACP, AAHIVP, CDCES, discusses data and recommendations for providing HIV prevention options as a strategy to support PrEP persistence and engagement, including: Postexposure prophylaxis (PEP) recommendations and the data for PEP-in-Pocket Offering PrEP to everyone who receives PEP Currently recommended …

1
Selected FXR Agonist PBC Studies: Conference Coverage of AASLD 17:36

4M ago17:36

17:36

During the 2023 American Association for the Study of Liver Diseases conference, exciting and important results from many primary biliary cholangitis (PBC) clinical trials were reported, including 3 late-breaking studies on the PPAR-δ agonist seladelpar, the dual PPAR agonist elafibranor, and the combination of the FXR agonist obeticholic acid and …

1
PrEP Talks: Strategies for Advanced Practice Providers to Increase Uptake 25:02

4M ago25:02

25:02

In this episode, Dr Tavell Kindall and Jona Tanguay discuss actionable strategies for advanced practice providers to increase the frequency at which PrEP is offered and initiated in primary care settings. Topics covered include: Available training resources on how to offer PrEP in primary care Affordable, accessible PrEP options, including patient …

1
Where We Want to Be: The Search for a Cure for HIV 52:41

4M ago52:41

52:41

In this third of 3 episodes, global HIV experts and advocates discuss the current status of HIV cure research, including key concepts to understand and communicate when counselling patients, colleagues, and the broader community on HIV cure: Latest understanding of the viral reservoir New insights and questions on the best timing for cure intervent…

1
CRE-ating Success: How I Use Rapid Diagnostic Tests to Manage Carbapenem-Resistant Enterobacterales Bacteremia 15:53

5M ago15:53

15:53

In this podcast, Julie Ann Justo, PharmD, MS, FIDSA, BCPS, discusses treatment of carbapenem-resistant Enterobacterales (CRE) infections, including: Burden of CRE infections in the United States Mechanisms of resistance Changing epidemiology Use of rapid diagnostic tests IDSA guidance recommendations, including supporting data Approach to designing…

1
Investigational PPAR-delta Agonist for PBC Treatment and Race-Based Considerations for PBC Diagnosis: Conference Coverage of AASLD 9:18

5M ago9:18

9:18

During the 2023 American Association of the Study of Liver Diseases (AASLD) conference, exciting and important results from many primary biliary cholangitis (PBC) clinical trials were reported, including 3 late-breaking studies on the PPAR-delta agonist seladelpar, the dual PPAR agonist elafibranor, and the combination of the FXR agonist obeticholi…

1
PrEP Talks: Uptake in Young Adults and Adolescents 19:43

5M ago19:43

19:43

In this episode, Errol L. Fields, MD, PhD, MPH, and Armonté Butler, MPH, a pre-exposure prophylaxis (PrEP) advocate, discuss strategies for overcoming barriers to uptake of PrEP for HIV in adolescents and young adults, based on the unique needs of this patient population. Topics covered include: Methods for building trust between patients and provi…

1
Investigational Dual PPAR Agonist, FXR Agonist With Fibrate, and Hyperlipidemia in People With PBC: Conference Coverage of AASLD 9:01

5M ago9:01

9:01

During the 2023 American Association of the Study of Liver Diseases (AASLD) conference, exciting and important results from many primary biliary cholangitis (PBC) clinical trials were reported, including 3 late-breaking studies on the PPAR-delta agonist seladelpar, the dual PPAR agonist elafibranor, and the combination of the FXR agonist obeticholi…

1
Are We Making Our Patients Fight for PrEP? 3:52

5M ago3:52

3:52

In this episode, Martin Rios discusses how pre-exposure prophylaxis (PrEP) persistence depends on healthcare professional knowledge, including: Their own experiences with the various PrEP providers they have seen The relief that has come with seeing PrEP providers who are supportive and knowledgeable about the different PrEP options The challenges …

1
Q&A on HIV PrEP: Episode 6 on Cisgender Women 35:35

5M ago35:35

35:35

In this episode, Meredith Clement, MD, and Whitney C. Irie, MSW, PhD, discuss key considerations for pre-exposure prophylaxis (PrEP) uptake in cisgender women, including: How to incorporate conversations on PrEP during a short clinic visit Helpful resources about PrEP to share with patients Leveraging clinic staff to improve PrEP uptake and persist…

1
Expert Insight on Seminal New Clinical Trial Data Presented at the 2023 IGCS Conference Informing Treatment for Endometrial, Ovarian, and Cervical Cancers 30:29

5M ago30:29

30:29

In this episode, Brian Slomovitz, MD, MS, FACOG, and Keiichi Fujiwara, MD, PhD, share their thoughts and opinions on seminal data presented at the 2023 IGCS annual meeting for endometrial, ovarian, and cervical cancers, including: Phase III NRG GY018 trial of carboplatin and paclitaxel with or without pembrolizumab followed by pembrolizumab or plac…

1
The Rise of RSV: Updates on Seasonality 8:05

5M ago8:05

8:05

In this episode, Helen Y. Chu, MD, MPH, shares updates on RSV seasonality, including: Surveillance limitations due to the testing availability in adults Current 2023/2024 season trends, including predictions for other respiratory viruses (eg, influenza, SARS-CoV-2) Considerations for RSV administration RSV vaccine coadministration with influenza an…

1
Ready, Set, Vaccinate! RSV Vaccination for Older Adults 16:06

5M ago16:06

16:06

In this episode, Rick Zimmerman, MD, MPH, FAAFP, discusses RSV vaccines in older adults, including: Breakthroughs in RSV vaccine development RSV vaccine snapshot in older adults FDA-approved RSV vaccines for older adults CDC evidence to recommendations framework for vaccines RSV burden in older populations Benefits and harms of RSV vaccination RSV …

Подкасты, которые стоит послушать

Подкасты на тему CCO

Подкасты, которые стоит послушать

Краткое руководство